Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...
"Today, we serve over 1.3 crore customers, predominantly millennials, with substantial engagement and active participation ...
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug ...
Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo linked to the Bundibugyo strain of the virus. Unlike the more ...
A small number of experimental vaccines and therapies are being assessed, while global health authorities are also reviewing ...
Researchers have developed a technique that can identify errors caused by mutations linked to a range of genetic disorders, ...
Researchers have developed a technique that can identify errors caused by mutations linked to a range of genetic disorders, including forms of ...
2don MSN
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on day 1 as GMP soars to 42%
Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The ...
May 19, 2026 expert reaction to initial genomes of the Bundibugyo virus from the outbreak in the Democratic Republic of the Congo and Uganda . Scientists comment on the genomes of ...
Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...
Ebola and COVID-19 are viral diseases with different transmission methods and symptoms. Recent Ebola outbreaks in Africa have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results